BCL2L1 and acute myeloid leukemia: Further stratification of the AML patients in primitive (M0-M2) vs. differentiated (M4-M5) subgroups did not provide any significance; Additionally, we did not find a significant correlation between the MCL1/BCL2L1 ratio and UNBS1450 sensitivity in our panel of 14 cell lines (Supplementary Fig. S12G, H).